Lornoxicam is a non-steroidal anti-inflammatory drug of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. It is available in oral and. Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic (pain relieving), anti-inflammatory. Lornoxicam is a nonsteroidal anti-inflammatory drug with analgesic properties From: Profiles of Drug Substances, Excipients and Related Methodology,

Author: Nall Samutaur
Country: Kazakhstan
Language: English (Spanish)
Genre: Life
Published (Last): 6 July 2007
Pages: 412
PDF File Size: 18.61 Mb
ePub File Size: 15.18 Mb
ISBN: 440-4-19025-690-8
Downloads: 68375
Price: Free* [*Free Regsitration Required]
Uploader: Mogar

Cangrelor The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Cangrelor. Betamethasone Prrofile risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Lornoxicam. Flupirtine Lornoxicam may decrease the excretion rate of Flupirtine which could result in a higher serum level. Gemfibrozil The metabolism of Lornoxicam can be decreased when combined with Gemfibrozil. Captopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Lornoxicam is combined with Captopril.

Carbutamide The protein binding of Carbutamide can be decreased when combined with Lornoxicam. Doxapram The risk or lornoxiam of hypertension can be increased when Doxapram is combined with Lornoxicam. Ceftizoxime The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Lornoxicam.

Flurbiprofen The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Lornoxicam. Canrenoic acid The risk or severity of hyperkalemia can be increased when Lornoxicam is combined with Canrenoic acid. Celecoxib The risk or severity of adverse effects can be increased when Celecoxib is combined with Lornoxicam.

Osteoarthritis Osteoarthritis is one of the commonest joint disorder and occurs as we proflle due to wear and tear of a joint. Cloprednol The risk or severity of gastrointestinal irritation can be increased when Cloprednol is combined with Lornoxicam. Flumazenil Lornoxicam may decrease the excretion rate of Flumazenil which could result in a higher serum level.

Ebselen The risk or severity of adverse effects can pornoxicam increased when Lornoxicam is combined with Ebselen. Lamivudine Lornoxicam may decrease the excretion rate of Lamivudine which could result in a higher serum level.

  ARMSTRONG DUNE TEGULAR PDF

Ceftolozane Lornoxicam may decrease the excretion rate of Ceftolozane which could result in a higher serum level. Cefozopran The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Cefozopran.

Fluprednidene acetate The risk or severity of gastrointestinal irritation can be increased when Fluprednidene acetate is combined with Lornoxicam. Diltiazem The therapeutic efficacy of Diltiazem can be decreased when used in combination with Lornoxicam.

Imatinib The metabolism of Lornoxicam can be decreased when combined with Imatinib.

Lornoxicam – DrugBank

Fomepizole Lornoxicam may decrease the excretion rate of Fomepizole which could result in a higher serum level. Aurothioglucose Deug may decrease the excretion rate of Aurothioglucose which could result in a higher serum level. Choline magnesium trisalicylate The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Lornoxicam.

Esatenolol Lornoxicam may decrease the antihypertensive activities of Esatenolol. Ethyl biscoumacetate The risk or severity of gastrointestinal bleeding can be increased when Lornoxicam lornoxidam combined with Ethyl biscoumacetate.

Apixaban The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is lonoxicam with Apixaban. Ceforanide The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Lornoxicam.

Lornoxicam Drug Information – Indications, Dosage, Side Effects and Precautions

Irbesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Lornoxicam. Goserelin Lornoxicam may decrease the excretion rate of Goserelin which could result in a higher serum level. Amitraz The risk or severity of hypertension can be increased when Lornoxicam is combined with Amitraz. Iofetamine I The risk or severity of hypertension can be increased when Lornoxicam is combined with Iofetamine I Peak plasma concentration within hours oral or 25 min IM.

Idarucizumab Lornoxicam may decrease the proflle rate of Idarucizumab which could result in a higher serum level. Drugs A – Z. Canagliflozin Lornoxicam may decrease the excretion rate of Canagliflozin which could result in a higher serum level. Hexamethonium The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Lornoxicam. IUPAC name 3 E chloro[hydroxy pyridinylamino methylene]methyl-2,3-dihydro-4 H -thieno[2,3- e ][1,2]thiazinone 1,1-dioxide.

  GURDJIEFF EL ENEAGRAMA PDF

Bencyclane The risk or severity of hyperkalemia can be increased when Lornoxicam is combined with Bencyclane. Diatrizoate Lornoxicam may decrease the excretion rate of Diatrizoate which could result in a higher serum level. Combination with vitamin K antagonists like profiel increases the risk of bleeding.

Apramycin The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Apramycin. Metaxalone Lornoxicam may decrease the excretion rate of Metaxalone which could result in a higher serum level.

Lesinurad Lornoxicam may orofile the excretion rate of Lesinurad which could result in a higher serum level. Bicalutamide The metabolism of Lornoxicam can be decreased when combined with Bicalutamide. Albutrepenonacog alfa Lornoxicam may decrease the excretion rate of Albutrepenonacog alfa which could profild in a higher serum level. Clorgiline The risk or severity of hypertension can be increased when Clorgiline is combined with Lornoxicam.

Not recommended; contraindicated in months 7—9.

Lornoxicam – Indications, Dosage, Side Effects and Precautions

Cephalothin Group The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Lornoxicam. Amoxapine The risk or severity of hypertension can be increased when Amoxapine is combined with Lornoxicam.

Cyclopenthiazide The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Lornoxicam. Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Lornoxicam. Baclofen Lornoxicam may decrease the excretion rate of Baclofen which could result in a higher serum level.

Lurasidone The risk or severity of hypertension can be increased when Lornoxicam is combined with Lurasidone. Ergonovine The risk or severity of hypertension can be increased when Ergonovine is combined with Lornoxicam.